India
· Delayed Price · Currency is INR NSE:JBCHEPHARM Statistics
Total Valuation
NSE:JBCHEPHARM has a market cap or net worth of INR 249.82 billion. The enterprise value is 246.65 billion.
| Market Cap | 249.82B |
| Enterprise Value | 246.65B |
Important Dates
The last earnings date was Thursday, February 6, 2025.
| Earnings Date | Feb 6, 2025 |
| Ex-Dividend Date | Feb 7, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.99% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 71.34M |
Valuation Ratios
The trailing PE ratio is 39.03.
| PE Ratio | 39.03 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 13.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 38.54 |
| EV / Sales | 6.44 |
| EV / EBITDA | 25.00 |
| EV / EBIT | 29.57 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | n/a |
| Interest Coverage | 43.87 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 16.09% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 7.21M |
| Profits Per Employee | 1.21M |
| Employee Count | 5,311 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.55% in the last 52 weeks. The beta is 0.04, so NSE:JBCHEPHARM's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -2.55% |
| 50-Day Moving Average | 1,771.86 |
| 200-Day Moving Average | 1,819.94 |
| Relative Strength Index (RSI) | 38.09 |
| Average Volume (20 Days) | 135,909 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:JBCHEPHARM had revenue of INR 38.30 billion and earned 6.40 billion in profits. Earnings per share was 40.20.
| Revenue | 38.30B |
| Gross Profit | 25.03B |
| Operating Income | 8.34B |
| Pretax Income | 8.59B |
| Net Income | 6.40B |
| EBITDA | 9.87B |
| EBIT | 8.34B |
| Earnings Per Share (EPS) | 40.20 |
Balance Sheet
The company has 4.17 billion in cash and 1.00 billion in debt, giving a net cash position of 3.17 billion.
| Cash & Cash Equivalents | 4.17B |
| Total Debt | 1.00B |
| Net Cash | 3.17B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 32.12B |
| Book Value Per Share | 206.83 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 65.35%, with operating and profit margins of 21.77% and 16.71%.
| Gross Margin | 65.35% |
| Operating Margin | 21.77% |
| Pretax Margin | 22.43% |
| Profit Margin | 16.71% |
| EBITDA Margin | 25.76% |
| EBIT Margin | 21.77% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 15.25, which amounts to a dividend yield of 0.95%.
| Dividend Per Share | 15.25 |
| Dividend Yield | 0.95% |
| Dividend Growth (YoY) | 50.62% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.99% |
| Shareholder Yield | -0.04% |
| Earnings Yield | 2.56% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 18, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 18, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |